Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells

BACKGROUND: Systems biology leveraging multi-OMICs technologies, is rapidly advancing development of precision therapies and matching patients to targeted therapies, leading to improved responses. A new pillar of precision oncology lies in the power of chemogenomics to discover drugs that sensitizes...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraunhoffer, Nicolas A., Moreno Vega, Aura I., Abuelafia, Analía Meilerman, Morvan, Marie, Lebarbier, Emilie, Mary-Huard, Tristan, Zimmermann, Michael, Lomberk, Gwen, Urrutia, Raul, Dusetti, Nelson, Blum, Yuna, Nicolle, Remy, Iovanna, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189188/
https://www.ncbi.nlm.nih.gov/pubmed/37148583
http://dx.doi.org/10.1016/j.ebiom.2023.104602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189188/
https://www.ncbi.nlm.nih.gov/pubmed/37148583
http://dx.doi.org/10.1016/j.ebiom.2023.104602

Ejemplares similares